Pink SheetAmong the most notable new drugs in Japan's latest listing of reimbursement prices are Novo Nordisk A/S ’s blockbuster obesity therapy Wegovy (semaglutide), Chugai Pharmaceutical Co., Ltd. / Roche H
In VivoBack To Rising Leaders Gallery Marking the second edition of the ‘Rising Leaders’ list, In Vivo has highlighted entrepreneurs and innovators who represent the next wave of creativity in health care
In VivoNo noise and no drama. It is a precept that has been keenly respected by the staff and management of BTG Specialty Pharma over the past few years, much to the pride of its president, Anthony Higham. I
In VivoAfter a process lasting nearly a year and management presentations to multiple potential buyers, Boston Scientific CEO Mike Mahoney settled on SERB Specialty Pharmaceuticals, a Belgian company with a